|
1）Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet. 2006; 368(9542): 1155-63
|
|
|
|
2）Matsuzaki M, Kita T, Mabuchi H, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circulation J. 2002; 66(12): 1087-95
|
|
|
|
|
|
3）Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007; 369(9567): 1090-8
|
|
|
|
|
|
4）Okamura T, Tanaka H, Miyamatsu N, et al. The relationship between serum total cholesterol and all-cause or cause-specific mortality in a 17.3-year study of a Japanese cohort. Atherosclerosis. 2007; 190(1): 216-23
|
|
|
|
|
|
5）Tanabe N, Iso H, Okada K, et al. Serum total and non-high-density lipoprotein cholesterol and the risk prediction of cardiovascular events - the JALS-ECC. Circulation J. 2010; 74(7): 1346-56
|
|
|
|
|
6）Okamura T, Kokubo Y, Watanabe M, et al. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study. Atherosclerosis. 2009; 203(2): 587-92
|
|
|
|
|
|
7）Verschuren WM, Jacobs DR, Bloemberg BP, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA. 1995; 274(2): 131-6
|
|
|
|
|
|
8）Wilson PW, DAgostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18): 1837-47
|
|
|
|
|
|
9）DAgostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6): 743-53
|
|
|
|
|
|
10）Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11): 987-1003
|
|
|
|
|
|
11）Group NDR. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circulation J. 2006; 70(10): 1249-55
|
|
|
|
|
|
12）Ninomiya T, Kiyohara Y, Kubo M, et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int. 2005; 68(1): 228-36
|
|
|
|
|
|
13）Ninomiya T, Kiyohara Y, Tokuda Y, et al. Impact of kidney disease and blood pressure on the development of cardiovascular disease: an overview from the Japan Arteriosclerosis Longitudinal Study. Circulation. 2008; 118(25): 2694-701
|
|
|
|
|
|
14）Nakamura K, Okamura T, Hayakawa T, et al. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circulation J. 2006; 70(8): 954-9
|
|
|
|
|
|
15）Yasuno S, Ueshima K, Oba K, et al. Clinical significance of left ventricular hypertrophy and changes in left ventricular mass in high-risk hypertensive patients: a subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan trial. J Hypertens. 2009; 27(8): 1705-12
|
|
|
|
|
|
16）Mabuchi H, Kita T, Matsuzaki M, et al. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circulation J. 2002; 66(12): 1096-100
|
|
|
|
|
|
17）Furukawa Y, Taniguchi R, Ehara N, et al. Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry. Circulation J. 2008; 72(12): 1937-45
|
|
|
|
|
|
18）Kohsaka S, Kimura T, Goto M, et al. Difference in patient profiles and outcomes in Japanese versus American patients undergoing coronary revascularization (collaborative study by CREDO-Kyoto and the Texas Heart Institute Research Database). Am J Cardiol. 2010; 105(12): 1698-704
|
|
|
|
|
|
19）Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes. 1996; 45 Suppl 3: S14-6
|
|
|
|
|
|
20）Cheung N, Wang JJ, Klein R, et al. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007; 30(7): 1742-6
|
|
|
|
|
|
21）Yokoyama H, Oishi M, Kawai K, et al. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16. Diabet M. 2008; 25(12): 1426-32
|
|
|
|
|
|
22）Nishimura R, Nakagami T, Sone H, et al. Relationship between hemoglobin A1c and cardiovascular disease in mild-to-moderate hypercholesterolemic Japanese individuals: subanalysis of a large-scale randomized controlled trial. Cardiovasc Diabetol. 2011; 10: 58
|
|
|
|
|
|
23）馬渕 宏．J-LITチャート1．日本人における冠動脈疾患の一次予防 冠危険因子．動脈硬化．2001; 29: 296
|
|
|
|
|
|
24）馬渕 宏．危険因子の重なりと冠動脈イベント．The Lipid. 2007; 18: 63-72
|
|
|
|
|
|
25）Ninomiya T, Kubo M, Doi Y, et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke. 2007; 38(7): 2063-9
|
|
|
|
|
|
26）Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001; 161(11): 1413-9
|
|
|
|
|
|
27）Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipo-protein B in the prediction of coronary heart disease in men. Circulation. 2005; 112(22): 3375-83
|
|
|
|
|
|
28）Kitamura A, Noda H, Nakamura M, et al. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: the Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb. 2011; 18(6): 454-63
|
|
|
|
|